SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Mar 2, 2016

DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: March 2, 2016 · CIK: 0001533998 · Accession: 0001144204-16-085571

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-209002

Date

March 2, 2016

Author

Mark W. Viklund

Form

CORRESP

Company

DarioHealth Corp. (DRIO) (CIK 0001533998)

Letter

RE: LabStyle Innovations Corp. (CIK: 0001533998)

March 2, 2016

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Registration Statement No. 333-209002 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC, as representatives of the underwriters, hereby request acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time, March 3, 2016, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, please be advised that during the period from February 17, 2016 to March 2, 2016, we, acting on behalf of the several underwriters, distributed as many electronic copies of the preliminary prospectus dated February 16, 2016 and the preliminary prospectus dated February 25, 2016 as appears to be reasonable to secure adequate distribution.

By: H.C. WAINWRIGHT & CO., LLC By: Joseph Gunnar & Co., LLC

By: /s/ Mark W. Viklund

By: /s/ Eric Lord

Name: Mark W. Viklund

Name: Eric Lord

Title: Chief Executive Officer

Title: Head of Investment Banking/Underwritings

Show Raw Text

CORRESP
1
filename1.htm

March 2, 2016

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    LabStyle Innovations Corp. (CIK: 0001533998)

    Registration Statement No. 333-209002 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules
and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities
Act”), H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC, as representatives of the underwriters, hereby request
acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m.
Eastern Time, March 3, 2016, or as soon thereafter as practicable.

Pursuant to Rule 460 under
the Securities Act, please be advised that during the period from February 17, 2016 to March 2, 2016, we, acting on behalf of
the several underwriters, distributed as many electronic copies of the preliminary prospectus dated February 16, 2016 and the preliminary prospectus dated February 25, 2016 as appears to be
reasonable to secure adequate distribution.

    By:
    H.C. WAINWRIGHT & CO., LLC
    By:
    Joseph Gunnar & Co., LLC

    By:  /s/ Mark W. Viklund

    By:  /s/ Eric Lord

    Name: Mark W. Viklund

    Name:  Eric Lord

    Title: Chief Executive Officer

        Title: Head of Investment Banking/Underwritings

SecProbe.io